Identification of genes associated with tongue cancer in patients with a history of tobacco and/or alcohol use

Zhao,Yin; Fu,Dongna; Xu,Chengbi; Yang,Jingpu; Wang,Zonggui

doi:10.3892/ol.2016.5497

Identification of genes associated with tongue cancer in patients with a history of tobacco and/or alcohol use

Authors:
- Yin Zhao
- Dongna Fu
- Chengbi Xu
- Jingpu Yang
- Zonggui Wang
View Affiliations

Affiliations: Department of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Department of Otolaryngology, Changchun People's Hospital, Changchun, Jilin 130041, P.R. China
Published online on: December 14, 2016 https://doi.org/10.3892/ol.2016.5497
Pages: 629-638
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to identify genes associated with tongue cancer in patients with a history of tobacco and/or alcohol use. Microarray dataset GSE42023, including 10 tissue samples of tongue cancer from patients with a history of tobacco and/or alcohol use (habit group) and 11 tissue samples of non‑habit‑associated tongue cancer (non‑habit group), were downloaded from the Gene Expression Omnibus database. Differentially‑expressed genes (DEGs) between the habit and non‑habit groups were identified using the Linear Models for Microarray Data software package. The enrichment functions and pathways of these genes were subsequently predicted using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis. Transcription factors (TFs) and tumor‑associated genes (TAGs) were selected from the DEGs using the Encyclopedia of DNA Elements database and the TAG database, respectively. Protein‑protein interaction (PPI) networks for DEGs were constructed using Cytoscape. In addition, functional module analysis was performed using BioNet. This analysis identified 642 DEGs between the habit and non‑habit groups, including 200 upregulated and 442 downregulated genes. The majority of upregulated DEGs were functionally enriched in the regulation of apoptosis and the calcium signaling pathway. The majority of downregulated DEGs were functionally enriched in fat cell differentiation and the adipocytokine signaling pathway. In addition, 31 TFs and 42 TAGs were identified from the DEGs. Furthermore, this analysis demonstrated that certain DEGs, including AKT serine/threonine kinase 1 (AKT1), E1A binding protein p300 (EP300), erb‑b2 receptor tyrosine kinase 2 (ERBB2) and epiregulin (EREG), had high connectivity degrees in the PPI networks and/or functional modules. Overall, DEGs in a functional module, such as AKT1, EP300, ERBB2 and EREG, may serve important roles in the development of tongue cancer in patients with a history of tobacco and/or alcohol use. These DEGs are potential therapeutic targets for the treatment of tongue cancer in these groups.

View Figures

View References

1	Böckelman C, Hagström J, Mäkinen L, Keski-Säntti H, Häyry V, Lundin J, Atula T, Ristimäki A and Haglund C: High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer. 104:1890–1895. 2011. View Article : Google Scholar : PubMed/NCBI
2	Sano D and Myers JN: Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
3	Gosselin BJ: Malignant Tumors of the Mobile Tongue. Medscape. Jun;2011.http://emedicine.medscape.com/article/847428-overviewAccessed April 3, 2015.
4	Liang XH, Lewis J, Foote R, Smith D and Kademani D: Prevalence and significance of human papillomavirus in oral tongue cancer: The Mayo Clinic experience. J Oral Maxillofac Surg. 66:1875–1880. 2008. View Article : Google Scholar : PubMed/NCBI
5	Liu Z, Wang H and Li Q: Tongue tumor detection in medical hyperspectral images. Sensors. 12:162–174. 2011. View Article : Google Scholar : PubMed/NCBI
6	Garavello W, Spreafico R and Gaini RM: Oral tongue cancer in young patients: A matched analysis. Oral Oncol. 43:894–897. 2007. View Article : Google Scholar : PubMed/NCBI
7	Moore SR, Johnson NW, Pierce AM and Wilson DF: The epidemiology of tongue cancer: a review of global incidence. Oral Dis. 6:75–84. 2000. View Article : Google Scholar : PubMed/NCBI
8	Sebastian P, Babu JM, Prathibha R, Hariharan R and Pillai MR: Anterior tongue cancer with no history of tobacco and alcohol use may be a distinct molecular and clinical entity. J Oral Pathol Med. 43:593–599. 2014. View Article : Google Scholar : PubMed/NCBI
9	Xie X, Clausen OP, De Angelis P and Boysen M: The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer. 86:913–920. 1999. View Article : Google Scholar : PubMed/NCBI
10	Seo J and Hoffman EP: Probe set algorithms: Is there a rational best bet? BMC Bioinformatics. 7:3952006. View Article : Google Scholar : PubMed/NCBI
11	Wettenhall JM and Smyth GK: limmaGUI: A graphical user interface for linear modeling of microarray data. Bioinformatics. 20:3705–3706. 2004. View Article : Google Scholar : PubMed/NCBI
12	Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki RA: The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
13	Gene Ontology Consortium, . Gene ontology consortium: Going forward. Nucleic Acids Res. 43:D1049–D1056. 2015. View Article : Google Scholar : PubMed/NCBI
14	Kanehisa M, Goto S, Furumichi M, Tanabe M and Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38:D355–D360. 2010. View Article : Google Scholar : PubMed/NCBI
15	ENCODE Project Consortium, . An integrated encyclopedia of DNA elements in the human genome. Nature. 489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
16	Chen JS, Hung WS, Chan HH, Tsai SJ and Sun HS: In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma. Bioinformatics. 29:420–427. 2013. View Article : Google Scholar : PubMed/NCBI
17	Von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P and Snel B: STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 31:258–261. 2003. View Article : Google Scholar : PubMed/NCBI
18	Kohl M, Wiese S and Warscheid B: Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
19	Beisser D, Klau GW, Dandekar T, Müller T and Dittrich MT: BioNet An R-Package for the functional analysis of biological networks. Bioinformatics. 26:1129–1130. 2010. View Article : Google Scholar : PubMed/NCBI
20	Ogryzko VV, Schiltz RL, Russanova V, Howard BH and Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:953–959. 1996. View Article : Google Scholar : PubMed/NCBI
21	Kalkhoven E: CBP and p300: HATs for different occasions. Biochem Pharmacol. 68:1145–1155. 2004. View Article : Google Scholar : PubMed/NCBI
22	Lahtz C and Pfeifer GP: Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol. 3:51–58. 2011. View Article : Google Scholar : PubMed/NCBI
23	Hasan S, Hassa PO, Imhof R and Hottiger MO: Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis. Nature. 410:387–391. 2001. View Article : Google Scholar : PubMed/NCBI
24	Moldovan GL, Pfander B and Jentsch S: PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007. View Article : Google Scholar : PubMed/NCBI
25	Debes JD, Sebo TJ, Lohse CM, Murphy LM, Haugen DA and Tindall DJ: p300 in prostate cancer proliferation and progression. Cancer Res. 63:7638–7640. 2003.PubMed/NCBI
26	Ionov Y, Matsui S and Cowell JK: A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA. 101:1273–1278. 2004. View Article : Google Scholar : PubMed/NCBI
27	Ju X, Katiyar S, Wang C, Liu M, Jiao X, Li S, Zhou J, Turner J, Lisanti MP, Russell RG, et al: Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci USA. 104:7438–7443. 2007. View Article : Google Scholar : PubMed/NCBI
28	Freeman-Cook KD, Autry C, Borzillo G, Gordon D, BarbacciTobin E, Bernardo V, Briere D, Clark T, Corbett M, Jakubczak J, et al: Design of selective, ATP-competitive inhibitors of Akt. J Med Chem. 53:4615–4622. 2010. View Article : Google Scholar : PubMed/NCBI
29	Pfisterer K, Fusi A, Klinghammer K, Knödler M, Nonnenmacher A and Keilholz U: PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetax. Head Neck. 37:471–478. 2015. View Article : Google Scholar : PubMed/NCBI
30	Amornphimoltham P, Patel V, Molinolo A and Gutkind JS: Head and Neck Cancer and the PI3K/Akt/mTOR Signaling Network: Novel Molecular Targeted Therapies. Signaling Pathways in Squamous Cancer. pp407–pp429. 2010.
31	Kong L, Schäfer G, Bu H, Zhang Y, Zhang Y and Klocker H: Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. Carcinogenesis. 33:751–759. 2012. View Article : Google Scholar : PubMed/NCBI
32	Castaneda CA, CortesFunes H, Gomez HL and Ciruelos EM: The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev. 29:751–759. 2010. View Article : Google Scholar : PubMed/NCBI
33	Eide PW, Cekaite L, Danielsen SA, Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal E, Lothe RA and Leithe E: NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway. Cell Signal. 25:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
34	Weber SM, Bornstein S, Li Y, Malkoski SP, Wang D, Rustgi AK, KuleszMartin MF, Wang XJ and Lu SL: Tobacco-specific carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces AKT activation in head and neck epithelia. Int J Oncol. 39:1193–1198. 2011.PubMed/NCBI
35	West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S and Dennis PA: Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 111:81–90. 2003. View Article : Google Scholar : PubMed/NCBI
36	Massarelli E, Liu DD, Lee JJ, ElNaggar AK, Lo Muzio L, Staibano S, De Placido S, Myers JN and Papadimitrakopoulou VA: Akt activation correlates with adverse outcome in tongue cancer. Cancer. 104:2430–2436. 2005. View Article : Google Scholar : PubMed/NCBI
37	Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, Sausville EA, Molinolo AA and Gutkind JS: Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: A potential target for UCN-01. Clin Cancer Res. 10:4029–4037. 2004. View Article : Google Scholar : PubMed/NCBI
38	Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK and Testa JR: AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 23:5853–5857. 2004. View Article : Google Scholar : PubMed/NCBI
39	Lundstrom TS and Sobel JD: Antibiotics for gram-positive bacterial infections: Vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin. Infect Dis Clin North Am. 18651–668. (x)2004. View Article : Google Scholar : PubMed/NCBI
40	Hardy KM, Booth BW, Hendrix MJ, Salomon DS and Strizzi L: ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 15:191–199. 2010. View Article : Google Scholar : PubMed/NCBI
41	Yarden Y and Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137. 2001. View Article : Google Scholar : PubMed/NCBI
42	Sosa MS, LopezHaber C, Yang C, Wang H, Lemmon MA, Busillo JM, Luo J, Benovic JL, KleinSzanto A, Yagi H, et al: Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell. 40:877–892. 2010. View Article : Google Scholar : PubMed/NCBI
43	Silva SD, Perez DE, Alves FA, Nishimoto IN, Pinto CA, Kowalski LP and Graner E: ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: Correlation with clinical outcomes. Oral Oncol. 44:484–490. 2008. View Article : Google Scholar : PubMed/NCBI
44	Lu Z, Jiang G, BlumeJensen P and Hunter T: Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol. 21:4016–4031. 2001. View Article : Google Scholar : PubMed/NCBI
45	Uribe P and Gonzalez S: Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapy. Pathol Res Pract. 207:337–342. 2011. View Article : Google Scholar : PubMed/NCBI
46	Nickerson NK, Gilmore JL, Allen KT, Riese DJ II, Nephew KP and Foley J: EGFR-Ligand signaling in breast cancer metastasis: Recurring developmental themes. 2011.